2.5mg Mounjaro not doing anything? Here's what the first pen is actually for

The first four weeks: your system is settling in, not ramping up

You're a week or two into treatment. The pen's in the fridge, you've done your first couple of injections, and you're watching the scales with quietly increasing impatience. Nothing. Maybe half a kilogram one way, half a kilogram back. It feels like nothing is happening.

Here's the honest picture: at 2.5mg, very little is happening in terms of weight loss, and that's the point. The opening dose of tirzepatide is sized to let your digestive system adapt to a new medicine, not to suppress your appetite aggressively. Tirzepatide activates two receptors involved in hunger and blood-sugar regulation (GIP and GLP-1) but at 2.5mg the signal is deliberately gentle. If you're wondering whether 2.5mg Mounjaro actually does anything at this early stage, the answer makes more sense once you understand the titration logic behind the whole programme.

Some people notice a slight reduction in hunger at this stage; others feel essentially no different. Both responses are within the normal range. If you're not losing weight on 2.5mg Mounjaro and wondering whether that's normal, it helps to understand that what matters at week four isn't the number on the scales, it's that you've tolerated the medicine well enough to step up. That step is where things begin to shift.

The NHS's tirzepatide guidance confirms that treatment is titrated progressively from the 2.5mg starting point, with dose increases guided by your prescriber. The NHS medicines page for tirzepatide sets out this schedule clearly if you want to read the official summary.

What changes at 5mg, and why weight loss is a slow build, not a switch

The 5mg pen is where the majority of people first notice a meaningful dip in appetite. Meals feel smaller before they're finished. The urge to snack in the evening fades a little. Those effects compound over weeks, not days, which is part of why patience in the first month is genuinely hard. Many people find themselves asking whether 2.5mg of Mounjaro will do anything for their weight, and it's worth reading through that experience because it's something a lot of people share.

At 5mg, gastric emptying slows more noticeably, meaning food stays in your stomach longer and the fullness signal arrives sooner. The cascade of appetite-related hormones that tirzepatide influences becomes stronger. Most clinicians expect to see the first clear weight movement at the 5mg stage, though individual responses vary considerably.

The landmark SURMOUNT-1 trial, published in the New England Journal of Medicine, reported the 20–21% average weight reduction at 15mg across 72 weeks, a figure often quoted in headlines. That result took the best part of a year and a half at a dose six times the starting strength. Comparing your four weeks on 2.5mg to that number is the wrong frame entirely. Weight loss with tirzepatide is a long, stepped process. What to expect at 5mg of Mounjaro gives a clearer sense of the trajectory from here.

One misconception worth putting down gently

A lot of people arrive at the 2.5mg stage believing that if they aren't losing weight, the medicine isn't working for them, and consider stopping. That conclusion is understandable but premature. Tirzepatide's mechanism doesn't simply activate at a fixed dose; it builds. If you're concerned that 2.5mg Mounjaro doesn't seem to be working, there are specific reasons why that's almost always expected at this stage, rather than evidence of non-response. It's evidence that you're at the start of a titration schedule, doing exactly what it's designed to do.

True non-response (where someone reaches their highest tolerated dose and loses less than 5% of their body weight after six months) is something NICE's appraisal of tirzepatide (TA1026) addresses directly, as a basis for reviewing whether to continue. That's a decision made by a prescriber at the appropriate point, not during the first pen.

If you're weighing up the full private cost context before deciding whether to continue into higher doses, the UK Mounjaro cost breakdown covers what a complete course realistically involves.

When to actually talk to your prescriber

There are situations where it's right to get in touch before your scheduled review rather than waiting. Contact your prescriber or a healthcare professional promptly if you experience severe or persistent stomach pain, particularly if it radiates towards your back, that's the symptom pattern associated with pancreatitis, which the MHRA flagged in a Drug Safety Update for GLP-1 medicines. Significant nausea that isn't settling after the first week or two, or any symptom that feels disproportionate, is also worth raising.

What doesn't warrant alarm: feeling that nothing is happening on the scale. That's the expected experience at 2.5mg. Our prescribers review every patient's progress before each repeat supply, nobody gets waved through automatically. If the 2.5mg period has raised questions, the FAQs cover many common ones, or you're welcome to reach out through our support team.

At the end of four weeks on 2.5mg, if you've tolerated it well, the clinical conversation moves to whether to step up to 5mg. That's the moment treatment, in the practical sense, begins. Speak to our prescribers if you'd like that conversation now.